The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
@Spotify
Your company is now debt free, well capitalised with a portfolio of six investments (details of which can be found on the Company's website - www.velatechplc.com) and cash on deposit, at 30 September 2020, of £1,628,000. The cash at 30 September 2020 includes proceeds of £925,480 generated as a result of the exercise of warrants during September. The Company has post period end invested £250,000 in Mode Global Holdings plc, a UK-based fintech group, as announced on 5 October 2020.
Under the terms of the Agreement, Vela will pay consideration of £2.35 million to SGS for the Economic Interest. Of the consideration payable, £1.1 million will be satisfied by the issue of 1,100,000,000 new ordinary shares in Vela (the "Consideration Shares"), at a price of 0.1p per Consideration Share, being a premium of 56.9 per cent. to the Company's closing mid-market price of 0.06375 pence on the day prior to this announcement. The Consideration Shares will be subject to a lock-in agreement until the successful completion of Phase II of the trial, named ARCADIA, or for a period of two months following completion of the ARCADIA trial, should the outcome of the trials not meet the minimum threshold. The remaining consideration of £1.25 million will be paid by Vela to SGS in cash, funded from the net proceeds of the Placing and from the Company's existing cash resources.
Mon, 19th Oct 2020 14:41
RNS Number : 5146C
Conduity Capital PLC
19 October 2020
19 October 2020
For immediate release
CONDUITY CAPITAL PLC
("Conduity Capital" or "the Company")
Warrant Update
The Company confirms that the qualifying criteria for the accelerated exercise of the Investor Warrants, of achieving a closing price over 1.5p for five consecutive days, has been met. The Board does not intend to call upon holders to exercise their warrants at this time, but reminds warrant holders that they are able to exercise at the time of their choosing, until the earlier of the expiry of an accelerated exercise period (if required by the Company) or 2 October 2021.
The Company is also pleased to announce that it is reviewing a number of potential reverse take-over targets and will update investors as and when appropriate.
~ End ~
I would like to see an investment in something that I cannot buy on the market myself to be honest. I'm sure they have their plan and are working it. I do wonder what will come first... breakout or RNS... just a matter of patience
@robsaunders Do you still stand by your below comment?
robsaunders
Posted in: VELA
Posts: 305
Price: 0.088
No Opinion
This is the Company 21 Sep 2020 07:27
That VELA are moving into
They will reverse into VELA and Vela will have a name change
Reverse takeover - interesting times
xxxx Producers of medicinal cannabis have been given the green light in principle to list their shares in London.
Haven't been on LSE bbs for a little while, especially this one as it started to move to the gutter. I have however regularly been searching users who post great info about SYME and Apunter2 is one of them. I hope you are reading this Apunter2, rest assured that you have had a massive impact on educating me and I really enjoy your posts.
@DDS_DocHoliday
NED is chair at PIRI, done some great business in technology space, attracting decent investors to the register
He also but MTR together back in the days, he's come in with the new money
And placees were scaled back heavily...
Latest similar transactions have rocketed
Bizarre reaction but good for top up and people sitting on sidelines looking for better entry. Wonder if the sellers have forgotten about next friday...
"Minor logistical issues arising from increased regional COVID-19 restrictions has meant that final proof of concept trials continue for the Capture & Signal Generation Modules and the results are now anticipated on 16 October 2020."
In case you haven't read the last update re Paraytec, the above sentence is about a 5 mins covid test!
8 October 2020
Braveheart Investment Group plc
("Braveheart" or the "Group")
Update on P harm2Farm
Braveheart Investment Group (AIM: BRH) has been advised by Pharm 2 Farm Limited ("P2F") of a short delay in the planned testing of its anti-viral face mask material.
The Health and Safety Executive ("HSE") and its Advisory Committee on Dangerous Pathogens, has revised the policy on working with coronavirus (SARS-CoV-2) and has scheduled an inspection at the test facility where P2F is conducting its trials. This has had the consequential effect of delaying the trial while HSE undertake an inspection of the CL-3 laboratory to ensure all the appropriate safeguards are in place. The laboratory is an established UK university laboratory with all the appropriate documentation in place and administered by international virology experts and Braveheart has been advised by P2F that it does not anticipate any problems with the inspections that would delay completion of the P2F trials beyond 30 November 2020.
The P2F team is working urgently with the University to overcome this problem but also to locate an alternative testing laboratory, if one should be required.
P2F has received a conditional order for 1 million face masks per month for a period of one year from 1 January 2021. This order is subject to contract and conditional on the masks successfully completing antiviral and other performance tests and receiving the necessary PPE certifications. The order is also conditional on the buyer entering into sales contracts to sell a similar volume of masks per month.
In readiness for commercial release, P2F will shortly make a patent application to protect its technology for producing the antiviral material, which it is confident could be applied to air filters, face masks and other PPE.
Elsewhere in its operations, P2F has now completed the initial trial of its proprietary zinc nanotechnology, with positive results, at a citrus farm in the UK. P2F will commence trials in the USA shortly and if success is replicated in the USA trials, it expects to launch this product in early 2021, for farmers to apply during the 2021 growing season. The product is part of the company's nSitu(TM) range of nano-agritech materials, designed to support commercial farmers around the world - in this case by helping to protect the USA's annual 8 million tons of citrus fruit crops, with an estimated value of such crops of over $3.3 billion.
Dipped toe in here
Does baffle me why people jump from a stock which is on the floor and now has a guy at the helm that returned 40 bags just this year at his other company... to one which only really has 2 bags left in it, max 3 at a push